Class I · Most seriousActive recall
NAD+ (Nicotinamide adenine dinucleotide) for Injection
A reasonable chance it could cause serious harm or death.
Does this affect you?
Check your lot numberLot#: GG121624-023, within expiry
Where it was soldUS Nationwide.
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Microbial Contamination of Sterile Products: elevated endotoxin levels
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | GenoGenix LLC |
Show the full FDA record
| Full product label | NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. |
| Recalling firm | GenoGenix LLC |
| Distribution | US Nationwide. |
| Recall initiated | 2025-07-30 |
| Report date | 2025-10-15 |
| Recall completed | — |
| Recall number | D-0094-2026 |
| Classification | Class I |
| FDA status | Ongoing |
| Origin on file | Boca Raton FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.